News & Updates

Induction therapy with risankizumab, a monoclonal antibody neutralizing interleukin-23p19, resulted in significantly higher clinical remission rates among patients with moderate-to-severe ulcerative colitis (UC) compared with placebo, according to the INSPIRE trial presented at AIBD 2023.

The combination of oral acitretin plus topical triamcinolone acetonide (TAC) appears to have superior efficacy than TAC alone in the treatment of patients with oral lichen planus, as shown in a study.

Infants with human nonpolio enterovirus (EV) central nervous system (CNS) infection often present without cerebrospinal fluid (CSF) pleocytosis, reports a study.

In older men, serum levels of dehydroepiandrosterone (DHEA) and testosterone correlate inversely with coronary artery calcification (CAC), partially independently from each other, a study has shown.

The final results of the pivotal phase III APPLY-PNH trial show sustained efficacy and safety of the oral factor B inhibitor iptacopan in anti-C5-treated patients with paroxysmal nocturnal haemoglobinuria (PNH) and persistent anaemia.

The novel, noninvasive ultrasound therapy is safe and may help improve valvular function in patients with calcified aortic stenosis, according to a study.

Infants born to mothers with rheumatoid arthritis (RA) during pregnancy are at risk of autism spectrum disorder (ASD), according to a study.

In the first-line treatment of locally advanced or metastatic nonsmall cell lung cancer (NSCLC) patients with EGFR exon 20 insertion (ex20ins) mutations, the investigational mobocertinib is safe and efficacious but not necessarily better than platinum-based chemotherapy, according to the phase III EXCLAIM-2 trial.